Inventor · disambiguated record
Hye-Shin Chung
Also filed as: CHUNG HYE-SHIN
11 granted patents·5 pending applications·41 citations·filing 2010–2025
86Inventor score
Top patents by PatentIndex Score
16 records- 0194US9982032B2Stable liquid formulation of fusion protein with IgG Fc domainALTEOGEN INC·Filed 2016·Granted May 29, 2018·19 cites·4 claims
- 0285US9814782B2Modified antibody in which motif comprising cysteine residue is bound, modified antibody-drug conjugate comprising the modified antibody, and production method for sameALTEOGEN INC·Filed 2013·Granted Nov 14, 2017·10 cites·16 claims
- 0377US12371683B2Hyaluronidase variants and pharmaceutical composition comprising the sameALTEOGEN INC·Filed 2019·Granted Jul 29, 2025·1 cites·49 claims
- 0475US11235065B2Antibody-drug conjugate comprising modified antibodyALTEOGEN INC·Filed 2017·Granted Feb 1, 2022·2 cites·12 claims
- 0575US9012606B2In vivo half life increased fusion protein or peptide maintained by sustained in vivo release, and method for increasng in vivo half-life using sameCHUNG HYE-SHIN·Filed 2010·Granted Apr 21, 2015·6 cites·5 claims
- 0672US11414476B2Method for producing fusion protein having IgG Fc domainALTEOGEN INC·Filed 2016·Granted Aug 16, 2022·1 cites·14 claims
- 0768US2025368976A1Novel hyaluronidase variants and pharmaceutical composition containing the sameALTEOGEN INC·Filed 2025·Application pending·0 cites
- 0865US12090210B2Antibody-drug conjugate comprising modified antibodyALTEOGEN INC·Filed 2021·Granted Sep 17, 2024·0 cites·11 claims
- 0965US9051395B2Alpha-1 antitrypsin variant, preparation method thereof and use thereofPARK SOON JAE·Filed 2012·Granted Jun 9, 2015·2 cites·7 claims
- 1062US2022348636A1Method for producing fusion protein having igg fc domainALTEOGEN INC·Filed 2022·Application pending·0 cites
- 1162US2022289864A1Pharmaceutical composition for subcutaneous injection comprising human hyaluronidase ph20 variant and drugALTEOGEN INC·Filed 2022·Application pending·0 cites
- 1256US11866492B2Antibody specifically binding to FOLR1 and uses thereofALTEOGEN INC·Filed 2019·Granted Jan 9, 2024·0 cites·10 claims
- 1352US2023250408A1Novel hyaluronidase variants with improved stability and pharmaceutical composition comprising the sameALTEOGEN INC·Filed 2021·Application pending·0 cites
- 1449US9821059B2Composition for stabilizing protein and pharmaceutical formulation comprising the sameALTEOGEN INC·Filed 2015·Granted Nov 21, 2017·0 cites·6 claims
- 1548US2017119903A1Modified antibody in which motif comprising cysteine residue is bound, modified antibody-drug conjugate comprising the modified antibody, and production method for sameALTEOGEN INC·Filed 2016·Application pending·0 cites
- 1640US9902753B2Method of purifying a long-acting human growth hormoneCJ HEALTHCARE CORP·Filed 2013·Granted Feb 27, 2018·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Hye-Shin Chung files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →